Literature DB >> 19282765

Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: the relevance of the biometric factors and the severity of symptoms.

Julio Ponce1, Belén Beltrán, Marta Ponce, Javier Zapardiel, Vicente Ortiz, Onofre Vegazo, Javier Nuevo.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) has a negative impact on health-related quality of life (HRQoL). AIM: (i) To evaluate HRQoL in the general Spanish population with GERD. (ii) To analyze the influence of biometric factors and symptoms profile on HRQoL.
MATERIALS AND METHODS: A multicenter and population-based evaluation was performed. Surveys were sent out to the general population and 335 responders (16%) fulfilled symptomatic criteria of GERD. They filled out two HRQoL questionnaires [Short Form-36 (SF-36) and Quality of Life in Reflux and Dyspepsia]. Biometric factors and symptoms profile were collected. The SF-36 physical and mental component summary scores were calculated.
RESULTS: Two hundred and fifty-two individuals (75.2%) participated. SF-36 and Quality of Life in Reflux and Dyspepsia (QoLRAD) punctuations were lower compared with the general population. Female sex, severity of symptoms, and nocturnal symptoms were associated with a greater deterioration of HRQoL. Obese participants had a negative impact on the physical component summary score, but mental component summary score was better than in participants with normal weight. Adjusted by age, punctuations of smokers, exsmokers, and nonsmokers were similar. No differences in HRQoL with regard to alcohol consumption were observed.
CONCLUSION: In participants who fulfill symptomatic criteria of GERD, the HRQoL is very deteriorated. The factors that worsen the QoL are being female, increase in BMI, and nocturnal symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19282765     DOI: 10.1097/MEG.0b013e328310abe9

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists.

Authors:  Fermín Mearin; Julio Ponce; Marta Ponce; Agustín Balboa; Miguel A González; Javier Zapardiel
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

2.  Correlation Between Symptom Severity and Health-Related Life Quality of a Population With Gastroesophageal Reflux Disease.

Authors:  Shou-Wu Lee; Teng-Yu Lee; Han-Chung Lien; Yen-Chun Peng; Hong-Jeh Yeh; Chi-Sen Chang
Journal:  Gastroenterology Res       Date:  2017-04-19

3.  EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies.

Authors:  Elsa López-Pintor; María Puig-Moltó; Blanca Lumbreras
Journal:  Int J Environ Res Public Health       Date:  2022-08-09       Impact factor: 4.614

4.  The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease.

Authors:  Ying Chen; Feng Wang; Yuanxi Jiang; Chen Wang; Liwen Yao; Ping Wu; Yili Tong; Huihui Sun; Shuchang Xu
Journal:  Gastroenterol Res Pract       Date:  2013-02-28       Impact factor: 2.260

5.  A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults.

Authors:  David Pierce; Mary Corcoran; Maria Velinova; Stuart Hossack; Mieke Hoppenbrouwers; Patrick Martin
Journal:  Drug Des Devel Ther       Date:  2015-02-27       Impact factor: 4.162

6.  Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.

Authors:  David A Johnson; Anne Le Moigne; Jing Li; Charles Pollack; Peter Nagy
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.